BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Budgett RF, Bakker G, Sergeev E, Bennett KA, Bradley SJ. Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases? Front Pharmacol 2022;13:893422. [PMID: 35645791 DOI: 10.3389/fphar.2022.893422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Holter KM, Pierce BE, Gould RW. Metabotropic glutamate receptor function and regulation of sleep-wake cycles. International Review of Neurobiology 2023. [DOI: 10.1016/bs.irn.2022.11.002] [Reference Citation Analysis]
2 Li SH, Abd-elrahman KS, Ferguson SS. Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases. Pharmacology & Therapeutics 2022;239:108275. [DOI: 10.1016/j.pharmthera.2022.108275] [Reference Citation Analysis]